Search Results 1681-1690 of 17003 for Green Birth Control
The purpose of this study is to identify a new population of cells in the blood that may be contributing to allergic inflammation in atopic asthmatics.
... population. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
This is a Phase 2, multicenter, open-label study to evaluate the efficacy and safety of luspatercept in subjects with MPN-associated myelofibrosis and anemia ...
... population health. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
About this study. Study AG221-C-001 is a Phase 1/2, multicenter, open-label, dose-escalation, safety, PK/PD, and clinical activity evaluation of orally ...
... population for future clinical studies. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
... population who have completed the standard protocol. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed and tested a new 3D surface scanning approach that gives neurosurgeons even greater precision when ...
To gain specialized training in resilience, time management and burnout prevention. Physicians who visit the Mayo Clinic Physician Health Center consult ...
physically active. But the appeal of using over-the-counter weight-loss pills to lose weight fast is hard to resist. Do these products lighten […] The post ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.